Table 3.
Subgroup analysis of statin therapy duration and recent statin use
| Model 1* Odds ratio (95% CI) |
Model 2** Odds ratio (95% CI) |
|
|---|---|---|
| No statin use | 1 (Reference) | 1 (Reference) |
| Cumulative duration < 6 months | ||
| Recent use within 6 months*** | 2.04 (1.69,2.47) | 1.48 (1.21,1.82) |
| No recent use | 1.17 (0.95,1.43) | 0.82 (0.65,1.02) |
| Cumulative duration ≥ than 6 months | ||
| Recent use within 6 months*** | 1.41 (1.23,1.61) | 1.0 (0.87,1.15) |
| No recent use | 1.15 (0.82,1.62) | 0.86 (0.61,1.23) |
*Model 1 was adjusted for age and sex
**Model 2 was adjusted for age, sex, drinking, smoking, regular exercise, body mass index, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, triglyceride, waist circumference and hypertension
***Recent use was defined as the presence of statin prescription within 6 months of outcome